Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0QJGOZ)
| ADC Name |
JP7560255B2 ControlADC53
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ControlADC53
Click to Show/Hide
|
|||||
| Organization |
Sumitomo Dainippon Pharma Co Ltd, Sumitomo Pharma Co Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.3
|
|||||
| Structure |
|
|||||
| Antibody Name |
Polatuzumab
|
Antibody Info | ||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||